article thumbnail

Moderna’s Covid-19 vaccine sales forecast slashed amidst strong competition

Pharmaceutical Technology

It was an exceptional year for Moderna’s vaccine Spikevax, with forecast sales of $19.5bn in 2022. Currently, Spikevax is the second bestselling Covid-19 vaccine behind Pfizer’s Comirnaty, which is in the leading position, with forecast sales of $37bn in 2022.

article thumbnail

FTC order could ease biopharma competition

European Pharmaceutical Review

to address the potential competitive harm Amgen’s $27.8 Consolidation in the pharmaceutical industry has given companies the power and incentive to engage in exclusionary rebating practices, which can lead to sky-rocketing prices on essential medications,” stated Henry Liu, Director of the FTC’s Bureau of Competition.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Goodbye 2023, Hello 2024!

Contrarian Sales Techniques

Reflecting on 2023 2023 has been a year like no other. Highlights of the Year 2023 has been a transformative year in the world of sales, marked by significant advancements and innovations. Highlights of the Year 2023 has been a transformative year in the world of sales, marked by significant advancements and innovations.

Sales 64
article thumbnail

Medical Sales Trends to Watch Out For in 2023

MedReps

Knowing what’s to come in the medical sales industry is not only interesting, but it could help you with your sales goals. If you know how to prepare and get ahead of your competition, reaching your goals will be that much easier. What does this mean for the medical sales representatives?

article thumbnail

Key Developments from AMCP 2023 on Blockbuster Generics, Diabetes Drugs, PBM Legislation, and More

PM360

Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. billion in sales. The product had sales of roughly $800 million per year.

article thumbnail

Biopharma sees strong Q2 2023 market cap growth

European Pharmaceutical Review

For 20 of the leading biopharmaceutical companies, the second quarter (Q2) of 2023 has brought an aggregate market capitalisation growth of 2.3 trillion in the Q1 of 2023 to $3.56 trillion in Q2 2023. Q2 2023 biopharma market capitalisation results Eli Lilly “Eli Lilly witnessed the largest market capitalisation growth of 36.1

article thumbnail

Guide to the AI Tools for Sales to Optimize Performance in 2023

Quantified

Sixty years later, the search for artificial intelligence (AI) has produced a market that is expected to reach nearly $165 billion in 2023 , with a forecasted compound annual growth rate (CAGR) of 38.1% Part of that growth comes from using AI tools for professional work, especially sales. There’s no shortage of AI sales tools.

Sales 52